Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Zimelidine (INN, BAN; brand names Zimeldine, Normud, Zelmid) , is an antidepressant medication of the selective serotonin reuptake inhibitor (SSRI) class, and the first SSRI antidepressant to be marketed.[2] It is a pyridylallylamine, and is structurally different from other antidepressants.
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Buy Zimelidine (Zimeldine) Cas 56775-88-3
Zimelidine was developed in the late 1970s and early 1980s by Arvid Carlsson, Hans Corrodi and Peter Berntsson, who were then working for the Swedish company Astra AB. Their work began with a series of antihistamines known as pheniramines that were found to block both serotonin and noradrenaline reuptake, and among these, brompheniramine was identified as the most potent serotonin reuptake blocker and was therefore selected as the starting point for their synthesis program, ultimately leading to the invention of zimelidine as a derivative of brompheniramine.[4] Zimelidine was first sold in 1982.[5]
While zimelidine had a very favorable safety profile comparing to other commonly used antidepressants like tricyclic antidepressants at the time it was developed, within a year and a half of its introduction, rare case reports of Guillain–Barré syndrome emerged that appeared to be caused by the drug, prompting its manufacturer to withdraw it from the market.[2][5][6] Its withdrawal, due to this unpredictable neurological side effect, marked a swift end to its clinical use despite its pioneering efficacy.[2][4] After its withdrawal, it was succeeded by fluoxetine (derived from the antihistamine diphenhydramine) and fluvoxamine in that order, and the other SSRIs.
Mechanism of action
The mode of action is a strong reuptake inhibition of serotonin from the synaptic cleft. Postsynaptic receptors are not acted upon.
| Product Name | Zimelidine |
|---|---|
| CAS | 56775-88-3 |
| Synonyms |
H 102 09, H-102-09, H10209, Hydrochloride, Zimeldine, Hydrochloride, Zimelidine, Zelmid, Zimeldine, Zimeldine Hydrochloride, Zimelidin, Zimelidine, Zimelidine Hydrochloride
|
| Molecular Formula | C16H17BrN2 |
| Molecular Weight | 317.22 g/mol |
Structural Identifiers
| SMILES | CN(C)CC=C(C1=CC=C(C=C1)Br)C2=CN=CC=C2 |
|---|---|
| InChI | InChI=1S/C16H17BrN2/c1-19(2)11-9-16(14-4-3-10-18-12-14)13-5-7-15(17)8-6-13/h3-10,12H,11H2,1-2H3/b16-9- |
| InChIKey | OYPPVKRFBIWMSX-SXGWCWSVSA-N |
Commercial & Availability
| Standard Pack Sizes | 25 mg / 50 mg / 100 mg / 500 mg / Bulk Custom |
|---|---|
| Availability | In Stock |
| Custom Synthesis | Available on request |
Handling Information
| Appearance | Solid powder |
|---|---|
| Solubility | In water, 190 mg/L at 25 °C (est) |
| Storage | Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Structure & Identifiers
Interactive Chemical Structure Model
Zimelidine: First-in-Class SSRI for SERT Research
Zimelidine (CAS 56775-88-3) is a pyridylallylamine-class selective serotonin reuptake inhibitor (SSRI), historically recognized as the first SSRI antidepressant to enter clinical development [1]. It is structurally distinct from both tricyclic antidepressants (TCAs) and later SSRIs, featuring a (Z)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridinyl)-2-propen-1-amine core [2]. Its primary mechanism is potent and selective inhibition of the serotonin transporter (SERT), with significantly lower affinity for norepinephrine and dopamine transporters . Notably, zimelidine produces an active metabolite, norzimelidine, which contributes substantially to its in vivo pharmacology and extended half-life [3].
Zimelidine Differentiation from SSRIs and TCAs
Zimelidine’s unique pharmacological profile prevents simple substitution with other SSRIs or TCAs. Unlike fluoxetine, which exhibits residual norepinephrine reuptake inhibition at higher concentrations, zimelidine demonstrates a markedly higher selectivity ratio for serotonin over norepinephrine uptake [1]. Compared to amitriptyline, a prototypical TCA, zimelidine shows negligible affinity for histamine H1, muscarinic acetylcholine, and α1-adrenergic receptors, eliminating anticholinergic and sedative side effects inherent to TCAs [2]. Furthermore, the contribution of its active metabolite norzimelidine introduces a distinct pharmacokinetic dynamic, with a half-life exceeding that of many comparator agents [3]. These distinctions are critical for researchers designing experiments where off-target pharmacology or metabolite activity must be tightly controlled or specifically exploited.
Zimelidine Quantitative Differentiation
Serotonin Uptake Selectivity vs. Fluoxetine
Zimelidine exhibits a significantly higher selectivity ratio for inhibiting serotonin (5-HT) uptake over noradrenaline (NA) uptake compared to fluoxetine. In rat brain synaptosome assays, zimelidine demonstrates an IC50 of 0.33 μM for 5-HT and 8.2 μM for NA, yielding a 5-HT/NA selectivity ratio of ~25-fold . In contrast, fluoxetine’s 5-HT/NA selectivity ratio is reported to be approximately 54-fold in some studies but can be as low as 14-fold in others, with a higher absolute potency for NA uptake inhibition (IC50 ~0.132 μM) than zimelidine [1]. This makes zimelidine a cleaner pharmacological tool for isolating serotonergic mechanisms with reduced noradrenergic interference.
H1 and Muscarinic Receptor Affinity vs. Amitriptyline
Zimelidine is virtually devoid of affinity for histamine H1 and muscarinic acetylcholine receptors, contrasting sharply with the TCA amitriptyline. While amitriptyline demonstrates high affinity for histamine H1 receptors (Kd = 0.5-1.1 nM) and muscarinic receptors (Ki = 11-24 nM), leading to sedation and anticholinergic effects [1], zimelidine showed negligible displacement of [3H]-mepyramine (H1) and [3H]-QNB (muscarinic) at concentrations up to 10 μM in human brain tissue [2]. This absence of receptor interaction is a
ZIMELIDINE DIHYDROCHLORIDE
![]() |
- $150 – $2200
- Product name: ZIMELIDINE DIHYDROCHLORIDE
- CAS: 56775-88-3
- MF: C16H17BrN2
- MW: 317.22
- EINECS:
- MDL Number:MFCD00069358
- Synonyms:cis-h102/09 ;cis-Zimelidine;H-102/09;(Z)-3-[1-(p-Bromophenyl)-3-(dimethylamino)propenyl]pyridine;(Z)-Zimelidine;3-(4-Bromophenyl)-N,N-dimethyl-3-(3-pyridinyl)-2-propen-1-amine;3-(p-bromophenyl)-n,n-dimethyl-3-(3-pyridyl)-allylamin ;Allylamine, 3-(p-bromophenyl)-N,N-dimethyl-3-(3-pyridyl)-
- aablocks
- American Custom Chemicals Corporation
- Biosynth
- Medical Isotopes, Inc.
- TRC
- Usbiological
- 1mg
- 2MG
- 5MG
- 10mg
- 25mg
- 50MG
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA00EB0T | Zimelidine | 1mg | $513 | 2026-05-28 | Buy |
| American Custom Chemicals Corporation | API0000889 | ZIMELDINE 95.00% | 5MG | $786.5 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | API0000889 | ZIMELDINE 95.00% | 2MG | $350 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | API0000889 | ZIMELDINE 95.00% | 50MG | $1963.5 | 2021-12-16 | Buy |
| Biosynth | FZ28762 | Zimeldine | 1mg | $150 | 2026-06-04 | Buy |
| Biosynth | FZ28762 | Zimeldine | 2mg | $231.3 | 2026-06-04 | Buy |
| Medical Isotopes, Inc. | 14207 | Zimeldine | 25mg | $2200 | 2021-12-16 | Buy |
| TRC | Z435000 | Zimeldine | 50mg | $1455 | 2021-12-16 | Buy |
| Usbiological | 257163 | Zimelidine dihydrochloride | 10mg | $310 | 2021-12-16 | Buy |
| Usbiological | 292107 | Zimeldine | 2mg | $460 | 2021-12-16 | Buy |
| Usbiological | Z0445 | Zimeldine ((Z)-3-(4-Bromophenyl)-N,N-dimethyl-3-(3-pyridinyl)-2-propen-1-amine, Zimelidine) ≥97% | 10mg | $1010 | 2026-06-04 | Buy |
| Usbiological | Z0445 | Zimeldine ((Z)-3-(4-Bromophenyl)-N,N-dimethyl-3-(3-pyridinyl)-2-propen-1-amine, Zimelidine) ≥97% | 5mg | $579 | 2026-06-04 | Buy |
Properties
Density :1.4039 (rough estimate)
refractive index :1.5500 (estimate)
storage temp. :Desiccate at RT
solubility :0.1 M HCl: 45 mg/mL
form :solid
color :white
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
Zimelidine has been banned worldwide due to serious, sometimes fatal, cases of central and/or peripheral neuropathy known as Guillain-Barré syndrome and due to a peculiar hypersensitivity reaction involving many organs including skin exanthema, flu-like symptoms, arthralgias, and sometimes eosinophilia. Additionally, zimelidine was charged to cause an increase in suicidal ideation and/or attempts among depressive patients.
ZIMELDINE is a small molecule drug with a maximum clinical trial phase of IV and is indicated for major depressive disorder.
One of the SELECTIVE SEROTONIN REUPTAKE INHIBITORS formerly used for depression but was withdrawn worldwide in September 1983 because of the risk of GUILLAIN-BARRE SYNDROME associated with its use. (From Martindale, The Extra Pharmacopoeia, 29th ed, p385)
Source and Classification
Zimeldine is classified under the category of psychoactive drugs, specifically as an antidepressant. Its chemical structure is characterized by a pyridyl group linked to an allylamine moiety, which contributes to its pharmacological activity. As a member of the pyridylallylamine family, zimeldine’s mechanism involves the inhibition of serotonin and norepinephrine reuptake, thereby enhancing their availability in the synaptic cleft.
Synthesis Analysis
Methods and Technical Details
The synthesis of zimeldine typically involves several key steps:
- Starting Materials: The synthesis begins with commercially available precursors such as pyridine derivatives and allylamines.
- Reactions: The process often employs methods such as nucleophilic substitution and condensation reactions to form the final compound. For example, one common synthetic route involves the reaction of 3-pyridylacetaldehyde with an appropriate allylamine under acidic conditions.
- Purification: Following synthesis, purification techniques such as recrystallization or chromatography are utilized to isolate pure zimeldine.
Recent studies have explored variations in synthesis that include radiolabeling for imaging studies, enhancing understanding of zimeldine’s interaction with serotonin transporters .
Molecular Structure Analysis
Structure and Data
Zimeldine has a complex molecular structure that can be represented as follows:
- Chemical Formula: C15H16N2
- Molecular Weight: Approximately 240.30 g/mol
- Structural Features: The molecule consists of a pyridine ring connected to an allylic amine group. The stereochemistry is crucial for its biological activity, with specific configurations influencing its potency as a serotonin reuptake inhibitor.
The three-dimensional structure can be analyzed using computational chemistry methods to predict conformational preferences and interactions with biological targets .
Chemical Reactions Analysis
Reactions and Technical Details
Zimeldine undergoes various chemical reactions that are significant for both its synthesis and metabolic pathways:
- Hydroxylation: Zimeldine can be metabolized in vivo to form hydroxylated derivatives, which may exhibit different pharmacological profiles.
- Dealkylation: This reaction leads to the formation of norzimeldine, a metabolite that retains some antidepressant activity.
- Reactivity with Electrophiles: The nitrogen atom in zimeldine’s amine group can participate in electrophilic substitution reactions, which can be exploited in further chemical modifications.
Research has shown that structural modifications can lead to varying degrees of serotonin transporter inhibition, impacting their therapeutic efficacy .
Mechanism of Action
Process and Data
Zimeldine exerts its antidepressant effects primarily through the inhibition of serotonin reuptake at the synaptic cleft:
- Serotonin Transporter Inhibition: By blocking the serotonin transporter, zimeldine increases serotonin levels in the synaptic space, enhancing neurotransmission.
- Norepinephrine Reuptake Inhibition: It also affects norepinephrine levels, contributing to its mood-enhancing effects.
- Neurotransmitter Interaction: Studies indicate that zimeldine may modulate other neurotransmitter systems indirectly, although its primary action remains on serotonin and norepinephrine .
Physical and Chemical Properties Analysis
Physical and Chemical Properties
Zimeldine exhibits several notable physical and chemical properties:
- Appearance: Typically presented as a white crystalline solid.
- Solubility: Soluble in organic solvents like ethanol and dimethyl sulfoxide but poorly soluble in water.
- Melting Point: The melting point is around 160–165 °C.
- Stability: Zimeldine is sensitive to light and moisture; thus, it should be stored in a cool, dry place.
These properties are crucial for formulation development in pharmaceutical applications .
Applications
Scientific Uses
Although zimeldine was withdrawn from clinical use due to safety concerns, it remains relevant in scientific research:
- Neuroscience Studies: It serves as a model compound for studying serotonin transport mechanisms and receptor interactions.
- Drug Development: Researchers explore analogs of zimeldine for potential therapeutic applications in treating depression with improved safety profiles.
- Radiolabeled Analogs: These compounds are utilized in imaging studies to visualize serotonin transporters in vivo using single-photon emission computed tomography (SPECT) techniques .
Properties
CAS Number
Product Name
IUPAC Name
Molecular Formula
Molecular Weight
InChI
InChI Key
SMILES
Solubility
Synonyms
H-102-09
H10209
Hydrochloride, Zimeldine
Hydrochloride, Zimelidine
Zelmid
Zimeldine
Zimeldine Hydrochloride
Zimelidin
Zimelidine
Zimelidine Hydrochloride
Canonical SMILES
Isomeric SMILES
Description
Zimelidine Dihydrochloride, is a selective 5-HT uptake inhibitor. It modulates nociception and induces hyperglycemia in vivo, and is an orally active antidepressant
-
Zimelidine (CAS 56775-88-3) | SERT Inhibitor | BenchChem
Buy Zimelidine (CAS 56775-88-3) from BenchChem. High-selectivity SERT inhibitor; 25-fold 5-HT/NA selectivity. In stock for global …
-
ZIMELIDINE DIHYDROCHLORIDE price,buy ZIMELIDINE …
Zimelidine Dihydrochloride, is a selective 5-HT uptake inhibitor. It modulates nociception and induces hyperglycemia in vivo, and is …
-
Buy Zimelidine (EVT-286972) | 56775-88-3 – evitachem.com
Zimeldine is classified under the category of psychoactive drugs, specifically as an antidepressant. Its chemical structure is …
-
ZIMELIDINE DIHYDROCHLORIDE | 56775-88-3 – ChemicalBook
ZIMELIDINE DIHYDROCHLORIDE (CAS 56775-88-3) information, including chemical properties, structure, melting …
-
Density: 1.4039 (rough estimate)
-
refractive index: 1.5500 (estimate)
-
Melting point: 193°C
-
storage temp.: Desiccate at RT
-
-
CAS 56775-88-3 Zimeldine – Analytical Products / Alfa Chemistry
Home Products Analytical Standards Pharmaceuticals, Illicit Drugs & Alcohol Enzyme Activators, Inhibitors & Substrates Zimeldine
CAS No : 56775-88-3| Chemical Name : Zimeldine| Product Name …
Zimeldine is a pyridylallylamine, and is structurally different from other antidepressants.
Zimelidine for Sale, Find Zimelidine Sale 56775-88-3 List – ECHEMI
ECHEMI provides 16 top grade Zimelidine products for sale. Find Zimelidine 56775-88-3 you need according to certification and …
-
Zimelidine | CAS 56775-88-3 | TargetMol | Biomol.com
Buy Zimelidine, CAS: 56775-88-3, item number: TGM-T29216-25mg from TargetMol at Biomol!
-
Zimeldine | 56775-88-3 | FZ28762 | Biosynth
Buy Zimeldine (FZ28762 56775-88-3) online. Biosynth supplies catalog, bulk, and custom products for the life sciences and …
-
Where to Buy CAS No.: 56775-88-3 | Zimeldine
CAT Number: R007392 CAS Number: 56775-88-3 Molecular Formula: C₁₆H₁₇BrN₂ Molecular Weight: 317.22 Purity: ≥95% Inquiry …






Reviews
There are no reviews yet.